首页 | 本学科首页   官方微博 | 高级检索  
检索        

乳腺癌患者外周血CK19mRNA检测对辅助化疗有效性监测的临床研究
引用本文:张新丽,刘希光,张明宾,李建哲.乳腺癌患者外周血CK19mRNA检测对辅助化疗有效性监测的临床研究[J].泰山医学院学报,2008,29(2):104-106.
作者姓名:张新丽  刘希光  张明宾  李建哲
作者单位:1. 泰山医学院附属泰安医院,山东,泰安,271000
2. 青岛大学医学院附属医院,山东,青岛,266003
摘    要:目的探讨乳腺癌血液微转移发生规律以及辅助化疗对血液微转移的影响。方法以60例乳腺癌术后患者为研究对象,根据临床分期分为3组(0~Ⅰ期、Ⅱ期、Ⅲ期),运用RT-PCR技术,以CK19mRNA为标志物,分别检测其辅助化疗前后血液微转移发生情况。结果①化疗前血液微转移阳性率为23.33%(14/60),其中0-Ⅰ期0%(0/9)、Ⅱ期16.22%(6/37)、Ⅲ期57.14%(8/14),三组之间差异有统计学意义(P<0.05)。②化疗结束血液微转移阳性率为3.33%(2/60),化疗前后血液阳性率差异有统计学意义(P<0.01)。结论临床分期越晚,出现微转移可能性越大。辅助化疗能降低血液中微转移阳性率,是减少术后转移改善预后的重要措施。

关 键 词:乳腺癌  微转移  外周血  细胞角蛋白19
文章编号:1004-7115(2008)02-0104-03
修稿时间:2007年10月25

Effect of adjuvant chemotherapy on micrometastasis in breast cancers' peripheral blood by means of detection of CK19 mRNA
ZHANG Xin-li,LIU Xi-guang,ZHANG Ming-bin,LI Jian-zhe.Effect of adjuvant chemotherapy on micrometastasis in breast cancers'''' peripheral blood by means of detection of CK19 mRNA[J].Journal of Taishan Medical College,2008,29(2):104-106.
Authors:ZHANG Xin-li  LIU Xi-guang  ZHANG Ming-bin  LI Jian-zhe
Institution:1(1.Central Hospital of Taian City; Taian 271000; China; 2. Medical School Hospital of Qingdao University; Qingdao 266003; China);
Abstract:Objective: To evaluate effect of adjuvant chemotherapy on the control of the micrometastasis of breast cancers by detection of CK19 mRNA in peripheral blood.Methods: Sixty postoperation-breast cancers studied were divided into 0~Ⅰ,Ⅱand Ⅲ three groups.CK19 mRNA was detected as the marker of peripheral micrometastasis by means of RT-PCR pre-and post-adjuvant chemotherapy individually.Results: Positive rate of micrometastasis in three groups was: 0-Ⅰstage 0%(0/9),Ⅱstage 16.22%(6/37) and Ⅲ stage 57.14%(8/14),wh...
Keywords:breast cancer  micrometastasis  peripheral blood  cytokertin 19(CK19)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号